This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
iot: Archive
Should QCOM Stock Be in Your Portfolio Post Solid Q1 Earnings?
by Supriyo Bose
With solid fundamentals and healthy revenue-generating potential driven by robust demand trends for AI chips, QCOM appears to be a solid investment proposition.
QCOMNegative Net Change MSFTNegative Net Change AVGONegative Net Change HPENegative Net Change
artificial-intelligence cloud-computing communications computers iot mobile semiconductor tech-stocks telecom
TAL Education (TAL) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
TALNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
World Acceptance (WRLD) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
WRLDNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should INTC Be in Your Portfolio Post Healthy Q4 Earnings?
by Supriyo Bose
INTC appears to be treading in the middle of the road and investors could be better off if they trade with caution.
INTCPositive Net Change AMDNegative Net Change NVDANegative Net Change
artificial-intelligence china communications computers earnings-estimates-revisions iot semiconductor tech-stocks
Should You Buy Blueprint Medicines (BPMC) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Can ANET Stock Sustain its Mojo With Arista 2.0 Strategy?
by Supriyo Bose
With healthy revenue-generating potential driven by robust demand trends, ANET appears poised for solid growth momentum.
CSCONegative Net Change ANETNegative Net Change
artificial-intelligence cloud-computing communications iot software tech-stocks
Qualcomm Surpasses Q1 Earnings Estimates on Record Revenues
by Zacks Equity Research
Record automotive and handset revenues enable QCOM to beat first-quarter fiscal 2025 earnings estimates.
QCOMNegative Net Change AKAMPositive Net Change WDAYNegative Net Change ANETNegative Net Change
artificial-intelligence communications computers earnings iot semiconductor tech-stocks
Should You Buy Pacira (PCRX) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
PCRXPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Is IBM Stock a Portfolio Must-Have Post Solid Q4 Earnings?
by Supriyo Bose
With solid fundamentals and healthy revenue-generating potential driven by robust demand trends, IBM appears to be a solid investment proposition.
AMZNNegative Net Change MSFTNegative Net Change IBMPositive Net Change
artificial-intelligence cloud-computing communications computers cybersecurity iot saas tech-stocks
Is Qualcomm Stock a Smart Buy Before Q1 Earnings Release?
by Supriyo Bose
With solid fundamentals and healthy revenue-generating potential driven by robust demand trends, QCOM appears to be a healthy investment bet.
QCOMNegative Net Change DTEGYPositive Net Change AVGONegative Net Change HPENegative Net Change
artificial-intelligence communications computers earnings-preview iot mobile semiconductor tech-stocks telecom
3 Wireless Stocks Set to Ride on Healthy Sector Dynamics
by Supriyo Bose
With solid demand for advanced networking architecture for increased broadband usage, the Zacks Wireless Equipment industry is likely to witness a healthy growth curve. QCOM, MSI and IDCC are set to thrive despite the near-term challenges.
QCOMNegative Net Change MSINegative Net Change IDCCNegative Net Change
artificial-intelligence cloud-computing communications iot mobile semiconductor tech-stocks
INTC Beats Q4 Earnings Estimates Despite Y/Y Lower Revenues
by Zacks Equity Research
Solid traction from an accelerated ramp-up of AI PCs helped INTC record better-than-expected fourth-quarter results.
INTCPositive Net Change AKAMPositive Net Change ANETNegative Net Change PINSNegative Net Change
artificial-intelligence communications computers earnings iot semiconductor tech-stocks
IBM Beats Q4 Earnings Estimates on Solid Cloud & AI Traction
by Zacks Equity Research
Strong portfolio mix, operating leverage and yield from productivity initiatives helped IBM beat fourth-quarter 2024 earnings estimates.
IBMPositive Net Change AKAMPositive Net Change ANETNegative Net Change PINSNegative Net Change
artificial-intelligence cloud-computing communications computers earnings iot tech-stocks
GLW Beats Q4 Earnings Estimates on Healthy Top-Line Improvement
by Zacks Equity Research
Solid traction in several verticals and optical connectivity products for GenAI applications helped GLW beat fourth-quarter earnings estimates.
AKAMPositive Net Change GLWNegative Net Change ANETNegative Net Change PINSNegative Net Change
artificial-intelligence cloud-computing communications earnings iot mobile tech-stocks
Trade Wars, Emerging Markets and DeepSeek: 3 Stocks to Watch
by Urmimala Biswas
Tariffs under Trump 2.0 could potentially shape emerging markets in 2025. Meanwhile, DeepSeek may turn the tables. Here are three stocks to watch: MELI, YTRA and WNS.
WNSPositive Net Change MELINegative Net Change YTRANegative Net Change
artificial-intelligence emerging-markets iot
Grupo Aeroportuario del Centro Norte (OMAB)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
OMABPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
UiPath (PATH) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
PATHNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
INTC Stock Before Q4 Earnings: A Smart Buy or Risky Investment?
by Supriyo Bose
INTC seems to be treading in the middle of the road and investors could be better off if they trade with caution.
INTCPositive Net Change AMDNegative Net Change NVDANegative Net Change
artificial-intelligence communications computers earnings-preview iot semiconductor tech-stocks
T Beats Q4 Earnings Estimates on Solid Subscriber Growth
by Zacks Equity Research
T surpasses fourth-quarter earnings estimates driven by a resilient business model and a diligent execution of operational plans.
TPositive Net Change AKAMPositive Net Change ANETNegative Net Change PINSNegative Net Change
cloud-computing communications earnings iot mobile tech-stocks
Vor Biopharma Inc. (VOR)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
VORPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
CLS Stock Before Q4 Earnings: A Smart Buy or Risky Investment?
by Supriyo Bose
CLS seems to be treading in the middle of the road and investors could be better off if they trade with caution.
JBLNegative Net Change FLEXNo Net Change CLSNegative Net Change AVGONegative Net Change
artificial-intelligence cloud-computing communications electronics iot tech-stocks
VZ Beats Q4 Earnings & Revenue Estimates on Solid Wireless Traction
by Zacks Equity Research
Healthy wireless subscriber additions and broadband growth help Verizon beat fourth-quarter 2024 earnings estimates.
VZPositive Net Change AKAMPositive Net Change ANETNegative Net Change PINSNegative Net Change
artificial-intelligence cloud-computing communications earnings iot mobile tech-stocks
Adidas AG (ADDYY) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
ADDYYPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
3 Instruments Stocks Likely to Beat Short-Term Industry Hardships
by Supriyo Bose
The increasing adoption of industrial automation, focus on higher energy efficiency and optimum resource utilization should drive the Zacks Instruments - Control industry. WTS, BMI and THR are well-positioned to gain from the evolving market dynamics.
WTSPositive Net Change BMIPositive Net Change THRNegative Net Change
artificial-intelligence automation industrial-products iot tech-stocks
3 Medical Info Systems Stocks to Buy as Stargate AI Drives Industry Prospects
by Urmimala Biswas
Zacks Medical Info Systems industry stocks like Enovis, Omnicell and Phreesia are expected to gain from the GenAI wave.
ENOVPositive Net Change OMCLPositive Net Change PHRNegative Net Change
artificial-intelligence iot medical medical-devices